Invention Grant
- Patent Title: Salts of 4-amino-N-(l-((3-chloro-2-fluorophenyl)amino)-6-methylisoquinolin-5-yl)thieno[3,2-D]pyrimidine-7-carboxamide, and crystalline forms thereof
-
Application No.: US16768535Application Date: 2018-11-29
-
Publication No.: US11649246B2Publication Date: 2023-05-16
- Inventor: Chang Hee Park , Seung Hyun Jung , Young Gil Ahn , Kwee Hyun Suh
- Applicant: Hanmi Pharm. Co., Ltd.
- Applicant Address: KR Hwaseong-si
- Assignee: Hanmi Pharm. Co., Ltd.
- Current Assignee: Hanmi Pharm. Co., Ltd.
- Current Assignee Address: KR Seoul
- Agency: Armstrong Teasdale LLP
- International Application: PCT/KR2018/014968 2018.11.29
- International Announcement: WO2019/107971A 2019.06.06
- Date entered country: 2020-05-29
- Main IPC: C07D495/04
- IPC: C07D495/04 ; A61P35/00 ; C07C309/00 ; C07C309/04 ; C07C309/30
![Salts of 4-amino-N-(l-((3-chloro-2-fluorophenyl)amino)-6-methylisoquinolin-5-yl)thieno[3,2-D]pyrimidine-7-carboxamide, and crystalline forms thereof](/abs-image/US/2023/05/16/US11649246B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to a crystalline form of a salt of 4-amino-N-(1-((3-chloro-2-fluorophenyl)amino)-6-methylisoquinolin-5-yl)thieno[3,2-d]pyrimidine-7-carboxamide, and a pharmaceutical composition containing the same. The crystalline form of the salt of the compound can be easily used for preparing a pharmaceutical composition containing the same as an active ingredient.
Public/Granted literature
Information query